Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TIGRT IVS

K-Number: K092550 · 2009-12-15

ApplicantLinatech, LLC
Decision Date2009-12-15
Product CodeIYE
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

TIGRT IVS is the device name listed in this FDA 510(k) record. The listed applicant is Linatech, LLC. It received FDA 510(k) clearance on 2009-12-15 under 510(k) number K092550. The device is classified under product code IYE. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TIGRT IVS?

TIGRT IVS is a medical device that received FDA 510(k) clearance on 2009-12-15. The listed applicant is Linatech, LLC. The 510(k) number is K092550.

When did TIGRT IVS receive FDA 510(k) clearance?

TIGRT IVS received FDA 510(k) clearance on 2009-12-15, under 510(k) number K092550.

Who is the listed applicant for TIGRT IVS?

The FDA 510(k) record lists Linatech, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TIGRT IVS?

The FDA product code for TIGRT IVS is IYE.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Linatech, LLC as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: IYE)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑